SIGN UP
LOG IN
MARKET
GENE
GENE
Genetic Technologies
NASDAQ
0.5960
-0.0030
-0.50%
After Hours: 0.5950 -0.001 -0.17% 19:09 12/07 EST
OPEN
0.6100
PREV CLOSE
0.5990
HIGH
0.6100
LOW
0.5800
VOLUME
29.07K
TURNOVER
0
52 WEEK HIGH
2.400
52 WEEK LOW
0.5600
MARKET CAP
11.46M
P/E (TTM)
-25.6897
1D
5D
1M
3M
1Y
5Y
Genetic Technologies: Prospectus [Rule 424(b)(3)]
Press release · 6h ago
Genetic Technologies: Report of foreign issuer
Press release · 12h ago
Cannabis Stock Gainers And Losers From December 4, 2023
Global compliance shares closed up 89.29% at $0.01. Indiva shares closed 38.93% up. Canopy gwth shares up 22.59%. Global hemp group shares closed down 76.68% at the end of the day. Cara therapeutic therapeutics closed down 3.77%.
Benzinga · 3d ago
Genetic Technologies: Prospectus [Rule 424(b)(3)]
Press release · 3d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Eyepoint pharmaceuticals stock increased by 378.8% to $31.65 during monday's pre-market session. Alterity therapeutics (nasdaq:athe) shares increased by 196.98%. Estrella immunopharma shares rose by 16.55%. Neximmune stock decreased by 36.7% during the session.
Benzinga · 3d ago
Why Hawaiian Airlines Shares Are Trading Higher By Over 180%; Here Are 20 Stocks Moving Premarket
Alaska air group announced plans to acquire hawaiian holdings in a deal worth $1.9 billion. Hawaiian holdings shares jumped 181.8% to $13.70 in pre-market trading. Shares of alaska air group, inc. Fell around 5% on sunday. Bitcoin mining company hut 8 mining corp. Shares rose 457.7% on friday.
Benzinga · 3d ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Hawaiian holdings (nasdaq:ha) stock is rocketing more than 174% after announcing a merger plan with alaska air. Wisa technologies shares are soaring over 162% after signing a five-year license agreement. Hawaiian holdings is one of the biggest pre-market stock movers for monday morning.
Investorplace · 3d ago
Weekly Report: what happened at GENE last week (1127-1201)?
Weekly Report · 3d ago
About GENE
Genetic Technologies Limited (GTG) is an Australia-based molecular diagnostics company. The Company offers predictive genetic testing and risk assessment tools. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its GeneType and EasyDNA brands. The Company operates through three segments: EasyDNA, AffinityDNA, and geneType / Corporate. The EasyDNA segment relates to EasyDNA branded test sales and expenses. The AffinityDNA segment relates to AffinityDNA branded test sales and expenses. The geneType / Corporate segment relates to geneType branded test sales and expenses, including corporate charges. The GeneType test is for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and type two diabetes in a single test. GeneType also offers integrated risk testing for a range of serious conditions. EasyDNA and AffinityDNA offer deoxyribonucleic acid (DNA) testing services.
Webull offers Genetic Technologies Limited (ADR) stock information, including NASDAQ: GENE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GENE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading GENE stock methods without spending real money on the virtual paper trading platform.